“…In patients with NCGS/WS, a systemic immune activation has been demonstrated; it was documented by increased serum levels of soluble CD14 and LPS-binding protein, as well as antibody reactivity to bacterial LPS and flagellin [ 10 ], enhanced expression of Toll-like receptor 2 (TLR2) [ 5 ], increased antibodies against gluten proteins [ 17 , 47 ], raised interferon gamma, interleukin (IL)-1 beta, IL-2, IL-12, IL-15, transforming growth factor (TNF) beta1, and TNF-α-expressing duodenal cells [ 3 , 29 ], increased serum levels of IL-8 and IL-15 [ 48 ], moderate intra-epithelial infiltration of eosinophils and lymphocytes, with increased inflammatory and regulatory CD4+ cells [ 6 , 13 , 17 , 47 , 49 , 50 ], and a high frequency of associated autoimmune diseases [ 7 , 51 ]. It has been hypothesized that individuals with NCGS/WS with a prevalent pathogenetic role for the FODMAPs, instead of gluten, may be a different patient population with less-prominent immunologic characteristics [ 6 ].…”